Detalhe da pesquisa
1.
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers.
Immunity
; 56(12): 2816-2835.e13, 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38091953
2.
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome.
Blood
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598835
3.
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Cell
; 146(6): 904-17, 2011 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21889194
4.
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Blood
; 141(23): 2841-2852, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877894
5.
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.
Genome Res
; 30(9): 1217-1227, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820006
6.
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Blood
; 137(26): 3604-3615, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649772
7.
Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice.
Blood
; 137(1): 61-74, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32640012
8.
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer.
PLoS Genet
; 14(10): e1007688, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325918
9.
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.
Nature
; 511(7511): 616-20, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043025
10.
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
Cancer Immunol Immunother
; 67(6): 861-872, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500635
11.
The power of proteasome inhibition in multiple myeloma.
Expert Rev Proteomics
; 15(12): 1033-1052, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427223
12.
Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.
Haematologica
; 103(7): 1218-1228, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622655
13.
NF-κB dysregulation in multiple myeloma.
Semin Cancer Biol
; 39: 68-76, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544796
14.
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
Br J Haematol
; 179(5): 756-771, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29048129
15.
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.
Proc Natl Acad Sci U S A
; 111(51): 18261-6, 2014 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25489091
16.
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.
Blood
; 123(10): 1461-9, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429336
17.
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.
Nat Rev Cancer
; 7(8): 585-98, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17646864
18.
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
Br J Haematol
; 169(6): 843-50, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26032514
19.
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
Br J Haematol
; 169(6): 851-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833301
20.
Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells.
J Immunol
; 190(3): 1360-71, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293352